BioCentury
ARTICLE | Company News

ALK-Abello, Japan Tobacco, Torii deal

February 11, 2013 8:00 AM UTC

ALK-Abello granted Japan Tobacco and its Torii Pharmaceutical subsidiary exclusive rights to develop and commercialize ALK-Abello's histamine dihydrochloride preparation in Japan. ALK-Abello markets t...